Celiac disease: Prevalence, diagnosis, pathogenesis and treatment
Top Cited Papers
- 1 January 2012
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (42), 6036-6059
- https://doi.org/10.3748/wjg.v18.i42.6036
Abstract
Celiac disease (CD) is one of the most common diseases, resulting from both environmental (gluten) and genetic factors [human leukocyte antigen (HLA) and non-HLA genes]. The prevalence of CD has been estimated to approximate 0.5%-1% in different parts of the world. However, the population with diabetes, autoimmune disorder or relatives of CD individuals have even higher risk for the development of CD, at least in part, because of shared HLA typing. Gliadin gains access to the basal surface of the epithelium, and interact directly with the immune system, via both trans- and para-cellular routes. From a diagnostic perspective, symptoms may be viewed as either "typical" or "atypical". In both positive serological screening results suggestive of CD, should lead to small bowel biopsy followed by a favourable clinical and serological response to the gluten-free diet (GFD) to confirm the diagnosis. Positive anti-tissue transglutaminase antibody or anti-endomysial antibody during the clinical course helps to confirm the diagnosis of CD because of their over 99% specificities when small bowel villous atrophy is present on biopsy. Currently, the only treatment available for CD individuals is a strict life-long GFD. A greater understanding of the pathogenesis of CD allows alternative future CD treatments to hydrolyse toxic gliadin peptide, prevent toxic gliadin peptide absorption, blockage of selective deamidation of specific glutamine residues by tissue, restore immune tolerance towards gluten, modulation of immune response to dietary gliadin, and restoration of intestinal architecture.Keywords
This publication has 97 references indexed in Scilit:
- Intranasal administration of a recombinant α-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic miceImmunology Letters, 2003
- Hla-Dq Typing in The Diagnosis of Celiac DiseaseThe American Journal of Gastroenterology, 2002
- Extended HLA haplotypes in a carib amerindian population: the Yucpa of the Perija RangeHuman Immunology, 2001
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000
- Sensitivity of Antiendomysium and Antigliadin Antibodies in Untreated Celiac Disease: Disappointing in Clinical PracticeThe American Journal of Gastroenterology, 1999
- Oral Delivery of AntibodiesClinical Pharmacokinetics, 1997
- Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.Gut, 1995
- Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.Archives of Disease in Childhood, 1990
- Changing Pattern of Childhood Coeliac Disease in FinlandActa Paediatrica, 1988